Upgrade to SI Premium - Free Trial

Zealand Pharma (ZEAL)

17.59 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Latest Headlines

Zealand Pharma - Transactions related to share buy-back program (week 23, 2026) June 8, 2026 11:05 AM - StreetInsider Zealand Pharma raises 10.7 million Danish kroner through warrant exercises June 8, 2026 11:00 AM - StreetInsider Zealand Pharma increases its share capital as a result of the exercise of employee warrants June 8, 2026 11:00 AM - StreetInsider Zealand Pharma announces Boehringer Ingelheim's survodutide Phase III trial in people living with obesity showed targeted 34% visceral and 63% liver fat reduction, while minimizing lean mass loss June 7, 2026 2:30 PM - Globe NewsWire Zealand Pharma announces Boehringer Ingelheim's survodutide Phase III trial in people living with obesity showed targeted 34% visceral and 63% liver fat reduction, while minimizing lean mass loss in p June 7, 2026 2:30 PM - StreetInsider Zealand Pharma reports positive obesity drug trial results at diabetes conference June 5, 2026 4:45 PM - StreetInsider New data from Phase 2 ZUPREME-1 trial at the American Diabetes Association 2026 Scientific Sessions further support potential of petrelintide to redefine the weight management experience for people li June 5, 2026 4:45 PM - StreetInsider Zealand Pharma A/S (ZEAL:DC) (ZEAL) PT Raised to DKK300 at Deutsche Bank June 4, 2026 4:07 AM - StreetInsider Zealand Pharma to participate in the Goldman Sachs Global Healthcare Conference June 2, 2026 11:00 AM - StreetInsider Zealand Pharma - Transactions related to share buy-back program (week 22, 2026) June 1, 2026 11:00 AM - StreetInsider Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons May 29, 2026 4:00 PM - Globe NewsWire Zealand Pharma to participate in the Jefferies Global Healthcare Conference May 27, 2026 11:00 AM - StreetInsider Zealand Pharma to Present Data at the American Diabetes Association's 2026 Scientific Sessions May 27, 2026 3:00 AM - Globe NewsWire Zealand Pharma to Present Data at the American Diabetes Association's 2026 Scientific Sessions May 27, 2026 3:00 AM - StreetInsider Zealand Pharma - Transactions related to share buy-back program (week 21, 2026) May 26, 2026 11:30 AM - StreetInsider Resolutions from Zealand Pharma's Extraordinary General Meeting 2026 May 26, 2026 10:00 AM - Globe NewsWire Resolutions from Zealand Pharma's Extraordinary General Meeting 2026 May 26, 2026 10:00 AM - StreetInsider Zealand Pharma - Transactions related to share buy-back program (weeks 19-20, 2026) May 14, 2026 11:00 AM - Globe NewsWire Zealand Pharma A/S (ZEAL:DC) (ZEAL) PT Lowered to DKK425 at Barclays May 12, 2026 5:09 AM - StreetInsider Zealand Pharma - Execution framework for share buy-back program May 7, 2026 1:05 AM - Globe NewsWire Zealand Pharma - Execution framework for share buy-back program May 7, 2026 1:05 AM - StreetInsider Zealand Pharma Announces Financial Results for the First Three Months of 2026 May 7, 2026 1:00 AM - StreetInsider Zealand Pharma initiates USD 200 million / DKK 1.3 billion share buy-back program May 7, 2026 12:55 AM - StreetInsider Zealand Pharma proposes Camilla Sylvest for board election May 1, 2026 9:01 AM - StreetInsider The Zealand Pharma Board of Directors proposes to elect Camilla Sylvest to the Board of Directors at an upcoming Extraordinary General Meeting May 1, 2026 9:01 AM - Globe NewsWire Zealand Pharma convenes Extraordinary General Meeting on May 26, 2026 May 1, 2026 9:00 AM - StreetInsider Zealand Pharma convenes Extraordinary General Meeting on May 26, 2026 May 1, 2026 9:00 AM - Globe NewsWire Zealand Pharma conference call on May 7 at 2pm CET (8am ET) to present first quarter 2026 financial results April 30, 2026 11:01 AM - StreetInsider Zealand Pharma advances petrelintide to phase 3 trials for weight management April 29, 2026 1:01 PM - StreetInsider Zealand Pharma and Roche to advance petrelintide, an amylin analog, to Phase 3 trials for chronic weight management April 29, 2026 1:01 PM - Globe NewsWire Zealand Pharma partner reports positive obesity drug trial results April 28, 2026 2:00 AM - StreetInsider Zealand Pharma announces Boehringer Ingelheim's novel glucagon/GLP-1 dual agonist survodutide achieved significant weight loss of 16.6% delivering meaningful metabolic improvement in people with April 28, 2026 2:00 AM - Globe NewsWire Boehringer's survodutide shows 16.6% weight loss in phase 3 trial April 28, 2026 2:00 AM - StreetInsider Zealand Pharma announces Boehringer Ingelheim's novel glucagon/GLP-1 dual agonist survodutide achieved significant weight loss of 16.6% delivering meaningful metabolic improvement in people with obesi April 28, 2026 2:00 AM - StreetInsider Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons April 22, 2026 4:00 PM - StreetInsider Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons April 19, 2026 4:05 PM - Globe NewsWire Zealand Pharma launches long-term incentive programs for Zealand Pharma’s Board of Directors, Corporate Management and employees for 2026 April 19, 2026 4:00 PM - Globe NewsWire Jefferies sees a buying opportunity in this biotech stock April 17, 2026 9:00 PM - StreetInsider Zealand Pharma A/S (ZEAL:DC) (ZEAL) PT Lowered to DKK505 at Jefferies April 16, 2026 5:29 AM - StreetInsider Zealand Pharma names Eric Rojas as VP of investor relations April 14, 2026 10:01 AM - StreetInsider Zealand Pharma Appoints Eric Rojas as Vice President and Head of Investor Relations April 14, 2026 10:00 AM - Globe NewsWire Zealand Pharma names Eric Rojas as VP of investor relations April 14, 2026 10:00 AM - StreetInsider Zealand Pharma Appoints Eric Rojas as Vice President and Head of Investor Relations April 14, 2026 10:00 AM - StreetInsider Total number of shares and voting rights in Zealand Pharma as of March 31, 2026 March 31, 2026 4:00 PM - StreetInsider Resolutions from Zealand Pharma's Annual General Meeting 2026 March 26, 2026 11:58 AM - StreetInsider Resolutions from Zealand Pharma's Annual General Meeting 2026 March 26, 2026 11:57 AM - Globe NewsWire Wolfe Research Starts Zealand Pharma A/S (ZEAL:DC) (ZEAL) at Outperform March 26, 2026 5:33 AM - StreetInsider Zealand Pharma Establishes U.S. Research Hub in Cambridge, Massachusetts to Expand Drug Discovery Capabilities and Accelerate Medicine Creation March 24, 2026 10:01 AM - Globe NewsWire Zealand Pharma Establishes U.S. Research Hub in Cambridge, Massachusetts to Expand Drug Discovery Capabilities and Accelerate Medicine Creation March 24, 2026 10:00 AM - StreetInsider Zealand Pharma increases its share capital as a result of the exercise of employee warrants March 19, 2026 5:00 PM - StreetInsider Zealand Pharma A/S (ZEAL:DC) (ZEAL) PT Lowered to DKK491 at Goldman Sachs March 19, 2026 4:39 AM - StreetInsider Zealand Pharma A/S (ZEAL:DC) (ZEAL) PT Lowered to DKK275 at Deutsche Bank March 12, 2026 5:39 AM - StreetInsider Zealand Pharma A/S (ZEAL:DC) (ZEAL) PT Lowered to DKK460 at JPMorgan March 11, 2026 2:22 AM - StreetInsider Full Article List